Professor Chloe Orkin is Professor of HIV Medicine at Queen Mary University of London and Consultant Physician at Barts Health NHS Trust where she has led the HIV clinical trials unit for the past 18 years. She has delivered more than 60 clinical trials of novel anti-viral agents to treat HIV, hepatitis C and SARS-CoV-2 thereby contributing to the licensing of 22 drugs. She is the global lead author for the first-ever long-acting injectable HIV therapy. Equity and justice are at the core of her academic and advocacy work. She directs the QMUL-based SHARE research collaborative for health equity. She is senior author on two global monkeypox case series and a clinical advisor to the WHO on moneypox and COVID-19. Chloe is the 80th President of the Medical Women's Federation (MWF). She has recently recorded an MWF Podcast on leadership. Chloe co-Chairs HIV Glasgow, one of the largest international conferences covering HIV and SARS CoV-2. She is immediate past Chair of the British HIV Association and a member of the governing council for the International AIDS Society.
